Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |